Ventricular-Arterial Coupling in Heart Failure with Preserved Ejection Fraction: A Bibliometric Review and Clinical Implications [0.03%]
射血分数保留的心力衰竭患者室壁耦合的文献计量学分析及临床意义
Tianzong Li,Yiran Luo,Lina Zhao et al.
Tianzong Li et al.
Heart failure remains a growing global health burden, and early disruptions in ventricular-arterial coupling (VAC) contribute to its pathogenesis, particularly in heart failure with preserved ejection fraction (HFpEF). We conducted an integ...
Positive Airway Pressure Therapies for Heart Failure: What Do the Trials Tell Us? [0.03%]
心衰患者的正压通气治疗：临床试验说了什么？
Jan Pec,Michael Arzt
Jan Pec
Sleep-disordered breathing (SDB) represents a modifiable treatment target in patients with heart failure (HF). Despite the evolution of positive airway pressure (PAP) therapy over the past several decades, randomised controlled trials have ...
Impact of Hypopnoea Classifications on the Assessment of Sleep Disordered Breathing in Heart Failure [0.03%]
呼吸暂停事件的分类对心力衰竭患者睡眠呼吸紊乱评估的影响
Sébastien Baillieul,Renaud Tamisier,Jean-Louis Pépin
Sébastien Baillieul
Sleep-related breathing disorders (SRBD), particularly central sleep apnoea and obstructive sleep apnoea, are highly prevalent among individuals with heart failure (HF). Accurate classification of SRBD is critical for accurate diagnosis and...
Home Sleep Apnoea Testing: Advances, Challenges and Considerations in Heart Failure [0.03%]
心力衰竭患者的家庭睡眠呼吸暂停监测：进展、挑战及考虑因素
Rebecca Steinberg,Andrew R Spector,Todd McVeigh et al.
Rebecca Steinberg et al.
Sleep-disordered breathing (SDB), including obstructive and central sleep apnoea, is highly prevalent in heart failure (HF) and contributes to adverse outcomes. In-lab polysomnography is the diagnostic gold standard, but is limited by cost ...
Glucagon-like Peptide-1 Receptor Agonists in Heart Failure: Mechanisms, Evidence and Identifying Optimal Candidates [0.03%]
心力衰竭中 glucagon 样肽 1 体激动剂的作用机制、证据及最佳适用人群的识别
Magdy Abdelhamid,Mostafa M Abdrabou,Emanuel Faris et al.
Magdy Abdelhamid et al.
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), established treatments for type 2 diabetes and obesity, exhibit cardiovascular benefits extending to heart failure (HF) with preserved ejection fraction (HFpEF). Mechanisms contributing ...
Emerging Pharmacological and Invasive Therapies for Hypertrophic Cardiomyopathy with Obstructive Physiology [0.03%]
梗阻性肥厚型心肌病的新兴药物和介入治疗
Emily Li-Wen Chu,Daniel Seung Kim,Ahmad Masri
Emily Li-Wen Chu
Hypertrophic cardiomyopathy is a prevalent condition characterised by ventricular hypertrophy, which results in left ventricular outflow obstruction in two-thirds of patients. Traditional pharmacological therapies, including β-blockers, ca...
Prevalence and Prognostic Significance of Malnutrition Assessed by Two Scoring Systems in Hospitalised Elderly Patients with Chronic Heart Failure [0.03%]
两种评分系统评估的住院老年慢性心力衰竭患者营养不良患病率及预后价值
Mohammed El-Sheikh,Nora Olsen El Caidi,Aginsha Kandiah et al.
Mohammed El-Sheikh et al.
Background: Malnutrition is common yet underrecognised in elderly patients (≥65 years) with chronic heart failure (CHF) and may accelerate disease progression through cytokine activation, autonomic dysfunction and cachex...
Cardiovascular Benefits of Spironolactone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction: Insights from a Win Ratio Analysis of the TOPCAT Trial [0.03%]
托普卡特研究试验中螺内酯用于射血分数轻度降低或保持正常的心力衰竭患者治疗的血管效应：赢比分析结果
Dung Viet Nguyen,Hoai Thi Thu Nguyen
Dung Viet Nguyen
Background: In recent heart failure (HF) trials, the win ratio statistical approach, developed to address the limitations of conventional methods, has been increasingly applied to better capture clinical benefits. The TOP...
Pre-implant Right Ventricular dP/dt Can Predict Severe Right Ventricular Failure After Left Ventricular Assist Device Implantation [0.03%]
术前右心室dp/dt可预测左心室辅助装置植入后的严重右心室功能障碍
Parth Visrodia,Aniket S Rali,Gabriel Hernandez et al.
Parth Visrodia et al.
Background: Right ventricular (RV) failure remains a major cause of morbidity and mortality after continuous flow left ventricular assist device (CF-LVAD) implantation. Previous risk assessment tools using pre-operative d...
High Troponin I in Patients Following Off-pump Coronary Artery Bypass Grafting [0.03%]
非体外循环冠脉搭桥术后高肌钙蛋白I血症
Hao Cui,Jinwei Zhang,Jianbo Yu et al.
Hao Cui et al.
Background: Blood troponin I (TnI) concentrations, the reasons for increases in TnI after coronary artery bypass grafting (CABG) and the effects of TnI on short- and long-term outcomes are not well understood. ...